Biomarkers of Basic Activities of Daily Living in Alzheimer's Disease

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2012 May 11

PMID 22571981

Citations 9

Authors

James R Hall

Leigh A Johnson

Robert C Barber

Hoa T Vo

A Scott Winter

Sid E OBryant

Affiliations

Soon will be listed here.

Abstract

Functional impairment is common in Alzheimer's disease (AD) and related to increased caregiver burden and institutionalization. There is a dearth of research investigating the relationship between specific biomarkers and basic activities of daily living (BADLs) such as toileting, feeding, dressing, grooming, bathing, and ambulating. The present study examined the relationship between serum based biomarkers and specific ADLs in a sample of AD patients. Data were collected from 196 participants enrolled in the Texas Alzheimer's Research and Care Consortium Project and diagnosed with AD. BADLs were measured using the Lawton-Brody Physical Self-Maintenance Scale. A panel of 22 biomarkers previously found to be related to AD pathology was used for the analysis. Stepwise regression modeling was used to assess the link between the biomarkers and BADLs. Results were also examined by gender. Nine of the 22 biomarkers were significantly related to BADLs. When stratified by gender, the biomarkers accounted for 32% of the variance in the males and 27% in females. The pattern of significant biomarkers differed by gender with IL 7 and Tenascin C significantly related to BADLs for females and IL 15 significantly related to BADLs for males. The results of this study indicated that a small number of serum based biomarkers are related to BADLs, and these biomarkers differed by gender.

Citing Articles

Brain interleukins and Alzheimer's disease.

Abdelhamed H, Hassan A, Sakraan A, Al-Deeb R, Mousa D, Aboul Ezz H Metab Brain Dis. 2025; 40(2):116.

PMID: 39891777 PMC: 11787210. DOI: 10.1007/s11011-025-01538-5.

APOE ε4-associated downregulation of the IL-7/IL-7R pathway in effector memory T cells: Implications for Alzheimer's disease.

Zhang Y, Cheng Y, Tang H, Yue Q, Cai X, Lu Z Alzheimers Dement. 2024; 20(9):6441-6455.

PMID: 39129310 PMC: 11497660. DOI: 10.1002/alz.14173.

Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease.

Weber G, Khrestian M, Tuason E, Shao Y, Pillai J, Rao S J Immunol. 2022; 208(10):2283-2299.

PMID: 35523454 PMC: 9117433. DOI: 10.4049/jimmunol.2100771.

The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Okada T, Suzuki H Front Immunol. 2021; 11:607587.

PMID: 33552066 PMC: 7859104. DOI: 10.3389/fimmu.2020.607587.

Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease.

Marongiu R Front Aging Neurosci. 2019; 11:242.

PMID: 31551757 PMC: 6743419. DOI: 10.3389/fnagi.2019.00242.

References

Hu W, Chen-Plotkin A, Arnold S, Grossman M, Clark C, Shaw L . Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol. 2010; 120(3):385-99. PMC: 2982700. DOI: 10.1007/s00401-010-0723-9. View

Reitz C, van Rooij F, de Maat M, den Heijer T, Hofman A, Witteman J . Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study. Neurobiol Aging. 2007; 29(6):874-81. DOI: 10.1016/j.neurobiolaging.2007.01.001. View

Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3):179-86. View

Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel M, Alexander T . Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol. 2008; 21(3):166-70. DOI: 10.1177/0891988708316860. View

Quinn T, Gallacher J, Deary I, Lowe G, Fenton C, Stott D . Association between circulating hemostatic measures and dementia or cognitive impairment: systematic review and meta-analyzes. J Thromb Haemost. 2011; 9(8):1475-82. DOI: 10.1111/j.1538-7836.2011.04403.x. View

Marshall G, Fairbanks L, Tekin S, Vinters H, Cummings J . Neuropathologic correlates of activities of daily living in Alzheimer disease. Alzheimer Dis Assoc Disord. 2006; 20(1):56-9. DOI: 10.1097/01.wad.0000201852.60330.16. View

Knopman D, Boeve B, Petersen R . Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003; 78(10):1290-308. DOI: 10.4065/78.10.1290. View

Cullum C, Saine K, Chan L, Martin-Cook K, Gray K, Weiner M . Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol. 2001; 14(2):103-8. View

Gallagher D, Mhaolain A, Crosby L, Ryan D, Lacey L, Coen R . Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2011; 26(2):110-4. PMC: 10845468. DOI: 10.1177/1533317510394649. View

10.

Pereira F, Yassuda M, Oliveira A, Forlenza O . Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int Psychogeriatr. 2008; 20(6):1104-15. DOI: 10.1017/S1041610208007631. View

11.

Simonsen A, McGuire J, Podust V, Hagnelius N, Nilsson T, Kapaki E . A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord. 2007; 24(6):434-40. DOI: 10.1159/000110576. View

12.

Mancinella A, Mancinella M, Carpinteri G, Bellomo A, Fossati C, Gianturco V . Is there a relationship between high C-reactive protein (CRP) levels and dementia?. Arch Gerontol Geriatr. 2009; 49 Suppl 1:185-94. DOI: 10.1016/j.archger.2009.09.028. View

13.

Gomez-Nicola D, Valle-Argos B, Pallas-Bazarra N, Nieto-Sampedro M . Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells. Mol Biol Cell. 2011; 22(12):1960-70. PMC: 3113763. DOI: 10.1091/mbc.E11-01-0053. View

14.

Okonkwo O, Alosco M, Griffith H, Mielke M, Shaw L, Trojanowski J . Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease. Arch Neurol. 2010; 67(6):688-96. PMC: 2888499. DOI: 10.1001/archneurol.2010.118. View

15.

Kim S, Song J, Kim S, Han C, Park M, Koh Y . Identification of peripheral inflammatory markers between normal control and Alzheimer's disease. BMC Neurol. 2011; 11:51. PMC: 3120663. DOI: 10.1186/1471-2377-11-51. View

16.

Zellner M, Veitinger M, Umlauf E . The role of proteomics in dementia and Alzheimer's disease. Acta Neuropathol. 2009; 118(1):181-95. DOI: 10.1007/s00401-009-0502-7. View

17.

Zuliani G, Guerra G, Ranzini M, Rossi L, Munari M, Zurlo A . High interleukin-6 plasma levels are associated with functional impairment in older patients with vascular dementia. Int J Geriatr Psychiatry. 2006; 22(4):305-11. DOI: 10.1002/gps.1674. View

18.

Locascio J, Fukumoto H, Yap L, Bottiglieri T, Growdon J, Hyman B . Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol. 2008; 65(6):776-85. PMC: 2662621. DOI: 10.1001/archneur.65.6.776. View

19.

OBryant S, Xiao G, Barber R, Reisch J, Hall J, Cullum C . A blood-based algorithm for the detection of Alzheimer's disease. Dement Geriatr Cogn Disord. 2011; 32(1):55-62. PMC: 3169374. DOI: 10.1159/000330750. View

20.

Schmitz T, Chew L . Cytokines and myelination in the central nervous system. ScientificWorldJournal. 2008; 8:1119-47. PMC: 2663591. DOI: 10.1100/tsw.2008.140. View